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Vitamin A deﬁciency (VAD) is prevalent in young children
throughout the developing world, aﬄicting 190 million chil-
dren under the age ﬁve worldwide (WHO, 2009). VAD is rated
as a severe public health problem in 73 countries, many
located in Sub-Saharan Africa (WHO, 2009). The impacts of
VAD in early childhood include not only night blindness,
but increased risk of other morbidity, as well as mortality.
In a systematic review covering 43 randomized controlled tri-
als (RCT) or cluster-RCTs, Mayo-Wilson, Imdad, Herzer,
Yakoob, and Bhutta (2011) found that vitamin A supplemen-
tation (VAS) reduced diarrhea incidence by 15% (based on 13
studies) and measles incidence by 50% (six studies) in children
aged six months to ﬁve years. Further, they found that VAS
reduced all-cause mortality for these children by 24% (43 stud-
ies); evidence that the authors rate as high quality. 1
According to Villamor and Fawzi (2005), the impact of vita-
min A on measles is due to increased lymphocyte proliferation,
which increases short-term antibody production. In contrast,
the reduction in severe diarrhea is likely due to the role of vita-
min A in restoring and maintaining gut mucosal integrity,
though there may be other immunological pathways. These
impacts are believed to be the strongest among children who
are undernourished or suﬀering from severe infection. While
reductions in these morbidities contribute to the impact of vita-
minA on all-causemortality, that impact is likely also bolstered
by the ability of vitaminA to increase T-cell counts, particularly
of the CD4 population, in children infected with HIV.
Akachi and Canning (2010) argue that improving nutrition
and reducing morbidity should be a key focus for development
interventions, as child morbidity is a strong predictor of
later-life outcomes. Indeed, individuals experiencing high
levels of childhood morbidity have been shown to have
reduced cognition, impaired adult stature, and be at increased
risk of later-life morbidity and mortality. 2 In Sub-Saharan
Africa in particular, achievements in reducing child mortality
may have outpaced reductions in childhood morbidity. This
hypothesis is based on the fact that, despite advances in reduc-
ing child mortality in Africa, today’s adult Africans are
shorter than their predecessors, which may be an indicator15of increased childhood morbidity (Akachi & Canning, 2010).
Reducing childhood morbidity may prove an eﬀective and sus-
tainable option for improving the productivity and longevity
of the next generation of Africans.
However, indeﬁnitely continuing high-frequency supple-
mentation can be costly. Edejer et al. (2005) estimated that
VAS costs $2.71 per recipient per dose. Relying on VAS alone,
at least quarterly dosing is required for maximum impact, at a
cost of $10.84/child/year. This implies that alleviating VAD
worldwide through supplementation alone would cost at least
$2.8 billion per year, implying a net present value of nearly $40
billion to alleviate VAD for the next 20 years. If other inter-
ventions can eﬀectively complement VAS, these may be useful
not only for reducing the cost of addressing VAD now, but
also as more sustainable future alternatives to VAS, once the
prevalence of VAD has been suﬃciently reduced.
One complementary approach to reducing VAD and other
micronutrient deﬁciencies is to encourage shifts toward more
micronutrient-dense diets (Ruel, Alderman, & Maternal
Child Nutrition Study Group, 2013). In rural areas, where
diets often include a great deal of own-produced food, such
interventions must occur through agriculture. Potential inter-
ventions include home gardening, various types of animal hus-
bandry, aquaculture, and biofortiﬁcation of staple crops
(Masset, Haddad, Cornelius, & Isaza-Castro, 2012). Yet many
of these strategies are still unproven in improving nutrition or
health (Bhutta et al., 2008; Ruel et al., 2013). The primary goal
of these programs is generally to improve dietary diversity, yet
there is little existing evidence that such interventions actually
aﬀect dietary diversity, not to mention health. Bhutta et al.
(2008) suggest that lack of evidence is partially due to a
general paucity of rigorous evaluations of agricultural
interventions to deal with micronutrient deﬁciencies.
One recent exception is the biofortiﬁcation of staple crops
(Bouis, Hotz, McClaﬀerty, Meenakshi, & Pﬁeﬀer, 2011). Bio-
fortiﬁcation involves the breeding of micronutrients into staple
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A, iron, and zinc deﬁciencies (Nestel, Bouis, Meenakshi, &
Pﬁeﬀer, 2006). Since biofortiﬁcation works through improving
the nutritional quality of the variety of staple crops that
households are already consuming, it is a promising, poten-
tially cost-eﬀective way to reduce VAD or other micronutrient
deﬁciencies (Gilligan, 2012). This approach is currently recom-
mended as a complement to ongoing eﬀorts of VAS, with the
potential to act as a longer-term replacement once the preva-
lence and severity of VAD in Africa has been signiﬁcantly
reduced.
In this work we examined the impact on child health of a
targeted biofortiﬁcation intervention for improving vitamin
A intakes among young children in northern Mozambique.
At the time of the intervention, 69% of children under the
age ﬁve in Mozambique were vitamin A deﬁcient (Aguayo,
Kahn, Ismael, & Meershoek, 2005). The intervention, called
the HarvestPlus Reaching End Users (REU) program, pro-
moted the cultivation of orange sweet potatoes (OSP) in home
gardens, rather than the traditionally grown white or yellow
varieties. The intervention was designed as a scaled up version
of the prior Toward Sustainable Nutrition Improvement
(TSNI) intervention that distributed OSP at a much higher
cost per beneﬁciary (Low et al., 2007). The intervention
included modules on production, consumption, and exchange
of OSP. The REU was successful in promoting OSP adoption,
increasing dietary intake of vitamin A, and decreasing VAD
prevalence among both women of child bearing age and chil-
dren (Hotz, Loechl, de Brauw et al., 2012; Hotz, Loechl,
Lubowa et al., 2012). In this paper, we study the impacts of
the REU on childhood morbidity. Primary outcome indicators
include prevalence and duration of diarrhea within the two
weeks prior to the interview.Table 1. Sample size by child age
Age in years 2006 2009 Total
0 93 45 138
1 212 137 349
2 218 112 330
3 14 175 189
4 3 193 196
5 0 119 119
Total 540 781 1,321
Mean age 1.30 2.88 2.24
Total U3 523 294 817
Mean age of U3 1.24 1.23 1.242. METHODS
(a) Intervention
The HarvestPlus REU project aimed to promote and dis-
tribute provitamin A-rich OSP in Mozambique with the goal
of reducing vitamin A deﬁciency among children under the
age ﬁve and women of childbearing age. The REU included
three components: seed systems, demand creation, and mar-
keting. In the seed systems component, vines for growing
OSP were distributed to households in treatment villages
and households were trained in planting OSP, how to disinfect
vines, and vine preservation. 3 In the demand creation compo-
nent, mothers in treatment households were oﬀered training
on the beneﬁts of consuming OSP, methods of preparing
OSP, and other general health messages. Finally, the project
included a marketing component to increase visibility of and
demand for OSP in local markets. 4 The project worked in
Zambe´zia with 144 farmer groups, approximately correspond-
ing to villages, and reached over 10,000 farmers in total. Vil-
lages were chosen for the study based on their agricultural
potential for growing sweet potatoes and maintaining sweet
potato vines over the dry season.
The impact evaluation included 36 villages spread over three
strata; two strata were in the north of Zambe´zia (Milange dis-
trict and Gurue´ district) and a third stratum in the south (com-
bining Mopeia and Nicoadala districts). Within strata, 2/3 of
villages were randomly selected to receive the program and 1/3
were reserved as controls, in which the program would be
implemented following endline data collection. 5 Villages
included in the impact evaluation sample were chosen toensure that no other health or agriculture-health interventions
were taking place simultaneously in those villages. The pro-
gram, as described, was implemented in 2007, 2008, and early
2009 with baseline data collection in 2006 (October to Decem-
ber) and endline data collection in June 2009 for dietary
intakes, nutrition, and morbidity, and in August and Septem-
ber of 2009 for socioeconomics and OSP production. Within
study villages, households were selected for inclusion in the
study based on the presence of a child under age three within
the household.
We ﬁrst compiled a list of households in the village with
children under 36 months, and then took a random sample
of 12 households from the list for the main nutrition study.
We then added four households from the list to those twelve
for measuring anthropometry, morbidity (diarrhea), and food
frequency.
(b) Data
Information regarding health and the frequency of con-
sumption of diﬀerent food items was collected at the baseline
for one child each from 553 households. At the endline, this
information was collected for the same children, plus addi-
tional children within these households who were born since
the baseline, as well as children in newly recruited households
from the same study villages. In total at the endline, 866 chil-
dren were included in this component from 673 households.
For this paper, OSP consumption is measured through the
food frequency questionnaire. The food frequency question-
naire gathered information on patterns of consumption of a
variety of foods and food groups, with an emphasis on vitamin
A-rich foods. Respondent guardians were asked about the
number of times children had consumed 26 speciﬁc foods dur-
ing the past seven days. Diarrhea and other health conditions
were measured using a set of relatively standard recall ques-
tions asked to a guardian regarding all children under the
age 5 resident in targeted households who were included in
the sample frame. The pertinent questions in this survey were
whether or not the child had diarrhea in the past 14 days, and
if so, how many days the diarrhea spell lasted.
Table 1 shows the sample size by age. The baseline recruit-
ment for this study yielded a sample of 540 children observed
in 2006 when under the age 3. In addition to following-up
these children in 2009, new children under the age three in
the same households were also enrolled at that time. 6 The
2009 sample included children aged zero to 5, so the mean
age for the 2009 sample was signiﬁcantly higher than in the
2006 sample. The ﬁnal row of Table 1 indicates that when
restricting the sample to those under the age of 36 months
Table 3. Child attrition by age
Age at baseline
6–11 months (%) 12–35 months (%)
Survey attrition rate 24.5 13.4
Local Infant mortality
rate (age 0–12 months)
14.7
Local Child mortality
rate (age 12–59 months)
6.8
Predicted mortality from
base to endline
12.1 5.1
Nonmortality attrition 12.4 8.3
Of baseline sample,
age group composes. . .
20 80
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tually identical.
Baseline characteristics of households and children in the
treatment versus control group are presented in Table 2. There
were no signiﬁcant diﬀerences in children’s characteristics
between treatment and control at the baseline, with the excep-
tion that children in treatment villages had a higher prevalence
of “other” illness (that is, other than diarrhea, respiratory ill-
ness, or fever).We do ﬁnd that households included in the study
had higher levels of education of the household head in treat-
ment villages relative to control villages. Therefore, we included
this variable as a control in our preferred speciﬁcation.
Attrition of households from the sample was 12%, and
attrition of children was 15.6%. However, attrition did not
vary by treatment status for either households or children.
The only signiﬁcant diﬀerence between those who were fol-
lowed up and others was the age and gender of the child.
As shown in Table 3, children who were younger at baseline,
speciﬁcally those aged six to 11 months, had a 25% attrition
rate, versus 13% for children aged 12–35 months. Diﬀerential
mortality rates by age group partially explained this diﬀer-
ence. In Zambe´zia province, infant mortality was 15%, while
mortality of children aged 12–59 months was only 6.8%
(MoH, 2009). Therefore, approximately half of the diﬀeren-
tial attrition was due to diﬀerential mortality; however, non-
mortality attrition from the study was also higher for
younger children. Additionally, attrition was 18% for girls
and 13% for boys, a diﬀerential that is not at all explained
by mortality diﬀerences. However, the diﬀerence was only
signiﬁcant at the 10% level, and given the number of charac-
teristics tested, at least one signiﬁcant diﬀerence was to be
expected. There were no signiﬁcant diﬀerences between those
attritting from the control relative to the treatment group
(columns four through eight of Table 2).
In previous work, Hotz, Loechl, de Brauw et al. (2012)
estimated the impact of the REU on OSP consumption and
dietary intake of vitamin A, using intensive 24-h dietaryTable 2. Baseline balance by treatme
Control Treatment Diﬀ
HOUSEHOLDS 184 369
Household size (members) 5.81 5.80 0.02
Children U5 3.58 3.49 0.09
Female headship 0.07 0.07 0.00
House area (sq m) 21.78 22.09 0.32
Consumption index (quintile) 2.96 3.03 0.07
Head education (highest grade) 2.66 3.27 0.62
Mother education (highest grade) 1.16 1.40 0.24
Grows OSP 0.07 0.10 0.03
CHILDREN 184 369
Age (mos) 21.56 21.62 0.07
Male 0.53 0.48 0.04
Ate OSP past week 0.05 0.06 0.01
HAZ 2.24 2.17 0.08
WAZ 1.20 1.17 0.04
Illness in past 2 weeks
Diarrhea 0.38 0.39 0.01
Respiratory illness 0.27 0.26 0.00
Fever 0.62 0.57 0.05
Other illness 0.15 0.23 0.08
Recent VAS 0.31 0.31 0.00
** Statistical signiﬁcance at the 5% level.
*** Statistical signiﬁcance at the 1% level.recalls, as well as the seven-day recall food frequencies. Chil-
dren’s consumption of OSP increased from 3% of the total
sweet potato intake in the baseline (not statistically diﬀerent
across groups) to 22% in control villages and 55% in treatment
villages at the endline. Average vitamin A consumption
among children at the baseline was about 200 lg retinol
activity equivalents (RAE)/day in all villages. At the endline,
children were consuming 600 lg RAE/day on average in
treatment villages and 350 lg RAE/day on average in control
villages. The increase in all villages is likely due to the
increased age and total consumption of the sample over time.
Among children aged 12–35 months, the prevalence of inade-
quate intakes was 12% among the treatment group at the end-
line, and 63% among the control. 7 The increase in average
intakes among children and the decrease in the prevalence of
inadequate intakes demonstrates that the REU was successful
at incorporating OSP into children’s diets when they were
available, and signiﬁcantly increased the adequacy of vitamin
A intakes among the target population in Mozambique. Here
we test whether this intervention exerted downstream impacts
on child morbidity.nt assignment and attrition status
Control Treatment
p-Value attritors attritors Diﬀ p-Value
20 47
0.916 5.47 5.70 0.23 0.671
0.570 3.21 3.51 0.30 0.527
0.924 0.16 0.11 0.05 0.569
0.697 23.56 21.01 2.55 0.393
0.509 2.83 2.98 0.15 0.685
0.005*** 2.75 3.15 0.40 0.593
0.163 1.45 1.45 0.00 0.996
0.305 0.00 0.15 0.15 0.232
27 58
0.937 18.55 22.10 3.55 0.176
0.322 0.52 0.34 0.17 0.131
0.735 0.00 0.04 0.04 0.364
0.601 2.58 2.26 0.32 0.549
0.785 1.47 1.34 0.13 0.795
0.755 0.37 0.38 0.01 0.938
0.931 0.11 0.24 0.13 0.166
0.233 0.41 0.55 0.14 0.22
0.038** 0.15 0.19 0.04 0.645
0.94 0.38 0.35 0.03 0.77
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We ﬁrst employed a linear probability model to estimate the
impact of exposure to the program on childhood morbidity.
Our outcome of interest was a binary indicator of whether
the child had experienced diarrhea in the past 14 days. 8 We
estimated
Dijt ¼ aþ b1ðT j  mtÞ þ b2T j þ b3mt þ X 0j/þ Z 0ijtcþ eijt
where Dijt was the outcome of interest for child i in household j
at time t. T j was an indicator variable that the household is in
a village assigned to treatment and mt indicated that the survey
round was in 2009 after the treatment occurred. The coeﬃcient
b1 on the interaction of T j and mt estimated the treatment
eﬀect. That is, the diﬀerential between the treatment and con-
trol group in the change over time in the outcome of interest.
The estimation also controlled for X j, a vector of household
characteristics, and Zijt, child characteristics at time t. The
variables included in X j and Zijt were educational attainment
of household head (highest grade completed), educational
attainment of the child’s mother, household’s wealth quintile,
size of home (m2), child’s gender, and child’s age in months.
The equation was estimated with and without these controls.
a was a constant, representing diarrhea prevalence among
the control group at the baseline (speciﬁc to the household
and child characteristics that were the excluded categories of
controls). eijt was a mean-zero error term. Standard errors of
the estimates were clustered at the village level. 9
While the random assignment of treatment status provides
the justiﬁcation for estimating a causal eﬀect, the hypothesis
was that OSP consumption was the pathway by which assign-
ment to treatment potentially impacted morbidity. Therefore
we tested this hypothesis directly with a two-stage least
squares (2SLS) estimation, using treatment assignment as an
instrument for child’s OSP consumption. That is, we used
treatment and time indicators, along with household and child
characteristics to predict whether a guardian reported that a
child ate OSP in the seven days before the survey and then esti-
mated the impact of predicted OSP consumption on the health
outcome of interest, correcting the standard errors for the use
of an estimated independent variable. We estimated
OcSP ijt ¼ aþ l1ðT j  mtÞ þ l2T j þ l3mt þ X 0j/þ Z 0ijtcþ eijt
where the independent variables were as described above. In
the second stage we estimated
Mijt ¼ aþ d1OcSP ijt þ X 0j/þ Z 0ijtcþ ijt:
Further, to ensure that diﬀerences in morbidity across ages
were not driving the results, we repeated these estimations
with the sample restricted to observations when a child was
under the age 3. In this case the mean ages in both the 2006
and 2009 samples were identical.
In addition to diarrhea occurrence as the outcome, we also
estimated analogous models with the outcome as the length of
the diarrhea (in days) for those with Dijt ¼ 1. Duration, in
combination with dehydration, is the primary indicator for
severity of diarrhea. Key risk factors for increased diarrhea
duration are malnutrition, as evidenced by low
weight-for-age, and decreased cell-mediated immunity (Baqui
et al., 1993; Bhutta et al., 2000; Black, Brown, & Becker,
1984). Cell-mediated immunity is an immune response that
does not involve antibodies but rather involves the activation
of phagocytes, T-lymphocytes (T-cells), and cytokines. Given
the ability of vitamin A to increase T-cells (Villamor &
Fawzi, 2005), it likely also improves cell-mediated immunity.3. RESULTS
The results for diarrhea occurrence within the past two
weeks are presented in Table 4. The ﬁrst three columns show
estimations that employed the full sample. The basic linear
probability model shown in column one suggests that both
treatment and control study villages experienced a reduction
in diarrhea prevalence between baseline and follow-up (likely
an artifact of the increased mean age in the 2009 sample).
However, the inclusion of household- and child-level controls
in the estimates shown in column two indicated that any
change in control villages was not distinguishable from zero.
In contrast, treatment villages showed reductions in diarrhea
prevalence of 11.4 percentage points, relative to the control
group (95% CI 2.0–20.8). This represented a 39% reduction
based on the mean indicator that 29% of children experienced
diarrhea in the two weeks prior to the survey. This eﬀect was
robust to the inclusion of all controls and is signiﬁcant at the
5% level. 10
Residence in a treatment village was the primary indicator
of exposure to the program, however, it is consumption of
OSP that was expected to impact the health of children. There-
fore, in column 3, we present the results of a two-stage least
squares estimation where we estimated the recent occurrence
of diarrhea as a function of whether the child regularly ate
OSP. Consumption of OSP was proxied by guardian-reports
of having eaten OSP in the week prior to the survey, and
was instrumented with treatment assignment. The ﬁrst stage
of this estimation is shown in Appendix Table 7. The 2SLS
results suggest slightly stronger and more precise impacts; that
is, children eating OSP were less likely to experience diarrhea
by 15.9 percentage points, an eﬀect that is signiﬁcant at the 1%
level (95% CI 5.9–25.9).
In order to ensure that the results were not driven by signif-
icant age diﬀerences in the baseline and follow-up samples (as
indicated in Table 1), the last three columns of Table 4 present
the same set of results for a sample restricted to children under
the age of 36 months (U36) at the time of the interview. In
these estimations, the mean age of children was the same in
both rounds of data collection. These results indicate a large
and robust reduction in diarrhea prevalence among the U36
population of treatment villages relative to control villages.
After including covariates, the reduction was estimated to be
18.9 percentage points on a mean of 36.6%, or a 52% reduc-
tion (95% CI 6.6–68.3). The 2SLS results provide a nearly
identical estimate, though more precisely estimated, signiﬁcant
at the 1% level (95% CI 6.7–29.9).
Table 5 presents results of estimates analogous to those in
Table 4, but that employed diarrhea duration as the outcome
of interest. That is, for the subsample of children with diarrhea
in the past two weeks, what was the duration of the illness (in
days). The point estimates were consistently negative, though
only the 2SLS estimates were statistically signiﬁcant. The esti-
mate in column three indicates that children eating OSP had
diarrhea duration that was reduced by 13% (0.6 days on a
mean of 4.7), signiﬁcant at the 10% level. The eﬀect was larger
and more precise for the younger (and consistently aged)
sub-sample. For these children, diarrhea duration was reduced
by 1.3 days (or 27%), signiﬁcant at the 1% level (95% CI 0.4–
2.2 days). 11(a) Heterogeneous results
Table 6 presents heterogeneous results by gender of child,
education of guardian, and recent VAS status, employing
interaction terms. Column 1 shows a 16.6 percentage point
Table 4. Diarrhea prevalence
Full Sample Under 36 mos. sample
LPM LPM IV LPM LPM IV
(1) (2) (3) (4) (5) (6)
OSP consumption .159*** .183***
(.051) (.059)
Treatment  Post .116** .114** .213*** .189**
(.049) (.048) (.075) (.078)
Treatment .014 .017 .009 .012
(.037) (.036) (.038) (.038)
Post .085** .012 .085 .075
(.034) (.041) (.061) (.066)
Male .048* .041* .067* .053*
(.024) (.024) (.033) (.032)
Age .005*** .005*** .007*** .007***
(.001) (.001) (.002) (.002)
Wealth quintile .018 .021 .020 .024
(.019) (.018) (.021) (.021)
House area .002 .001 .002 .002
(.003) (.003) (.003) (.004)
Head education .008 .009 .007 .008
(.006) (.006) (.008) (.008)
Mother education .008 .006 .011 .007
(.009) (.009) (.011) (.011)
Constant .368*** .525*** .543*** .355*** .557*** .594***
(.022) (.046) (.044) (.027) (.073) (.069)
Observations 1321 1304 1264 817 800 768
R2 .043 .078 .053 .023 .046 .025
Mean DV .291 .291 .289 .364 .366 .365
Note: The dependent variable is a binary indicator for whether the guardian reported that the child had experienced any diarrhea in the two weeks prior to
the interview. “OSP consumption” is a binary indicator for whether OSP was mentioned in a 7-day food frequency recall by the guardian (see text).
Estimations include stratum ﬁxed eﬀects. Standard errors are clustered at the village level and presented in parentheses.
* Statistical signiﬁcance at the 10% level.
** Statistical signiﬁcance at the 5% level.
*** Statistical signiﬁcance at the 1% level.
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the same for girls (p-value = .274), the linear combination
indicates that the point estimate for girl children is negative,
though not precisely estimated. We thus explored potential
pathways for any diﬀerential eﬀect. We ﬁrst considered
whether there was diﬀerential feeding of OSP by gender. A
t-test reveals that OSP consumption in 2009 was slightly
higher for boys, but did not signiﬁcantly diﬀer from girls,
either within the treatment group (p-value = 0.12) or overall
(p-value = 0.16). 12 We next considered a biological pathway,
whereby the same increase in vitamin A intake may have had
diﬀerential eﬀects by gender. We did ﬁnd that baseline diar-
rhea was signiﬁcantly higher among boys (43%) than girls
(35%; p-value = 0.06). This suggests that impacts may have
been greater for boys due to higher initial morbidity.
We also disaggregated the results both by education of the
mother, and by education of the household head. 13 Across
the 519 households in the sample, 27% of household heads
had completed the ﬁrst level of primary school (grade 5) or
higher. Completed education was considerably lower for
mothers. Only 54% of children had mothers reporting any
completed schooling, and only 7% had completed grade ﬁve
or higher. 14 Columns 2 and 3 of Table 6 show that for both
mothers and heads of household, having higher education gen-
erated a higher point estimate of treatment impact.
In particular, for mothers, we found that for children of
women who had completed the ﬁrst level of primary school,
there was a nearly 100% reduction in diarrhea resulting from
the program (30 percentage points, signiﬁcant at the 5% level;
column 2). Children of women with less education also bene-ﬁted, experiencing diarrhea reductions of 10 percentage points,
which was also signiﬁcant at the 5% level (linear combination).
We were able to reject that these eﬀects were the same at the
10% level of signiﬁcance, based on the interaction term.
Diaggregating household heads into the same education
groups, we could not reject that the eﬀects are the same for
both education groups based on the interaction term (column
3). However, children in households in which the household
head had not completed primary school exhibited an eﬀect
of only six percentage points, and the coeﬃcient estimate
was not signiﬁcantly diﬀerent from zero (linear combination).
Finally, column 4 of Table 6 explores the diﬀerential impact
of treatment for children who have received VAS within
6 months prior to the interview. We could not reject that the
beneﬁcial eﬀect is the same for children regardless of VAS sta-
tus (interaction term is not signiﬁcant). However, the point
estimates do suggest that the eﬀects are less for children who
have recently received VAS (linear combination is small and
not signiﬁcantly diﬀerent from zero). We used the same set
of coeﬃcients to compare the correlation between recent
VAS and diarrhea across children who are exposed to OSP
and those who are not. Linear combinations suggested that
for children without access to OSP, recent VAS was associated
with a 14.4 percentage point reduction in diarrhea (p-value
0.22), while for those with access to OSP, the association
was an increase of 0.5 percentage points. 15 While this was
nonexperimental, it similarly suggested that children beneﬁted
less from either OSP or VAS when they were already receiving
the other. Though in both cases we could not reject that the
eﬀects were the same regardless of other treatment.
Table 5. Diarrhea duration
Full sample Under 36 mos. sample
OLS OLS IV OLS OLS IV
(1) (2) (3) (4) (5) (6)
OSP consumption .612* 1.319***
(.371) (.472)
Treatment  Post .332 .384 .771 .842
(.655) (.663) (.650) (.678)
Treatment .307 .208 .194 .081
(.535) (.525) (.553) (.534)
Post .365 .022 .084 .020
(.553) (.491) (.546) (.530)
Male .512* .456* .510 .535*
(.276) (.276) (.315) (.321)
Age .020** .023** .057** .061**
(.008) (.009) (.025) (.025)
Wealth quintile .453 .474* .357 .426
(.272) (.255) (.304) (.291)
House area .057 .061 .047 .051
(.043) (.040) (.049) (.046)
Head education .039 .036 .067 .078
(.057) (.050) (.063) (.058)
Mother education .067 .079 .056 .070
(.085) (.086) (.101) (.105)
Constant 4.912*** 5.236*** 5.257*** 4.781*** 5.849*** 6.162***
(.404) (.440) (.452) (.400) (.646) (.536)
Observations 382 378 363 295 291 278
R2 .025 .060 .070 .031 .078 .090
Mean DV 4.730 4.741 4.705 4.861 4.876 4.881
Note: The dependent variable is the duration (in days) of the diarrhea episode, as reported by the parent; the samples include only those reporting an
episode in the two weeks prior to the interview. “OSP consumption” is a binary indicator for whether OSP was mentioned in a 7-day food frequency recall
by the guardian (see text). Estimations include stratum ﬁxed eﬀects. Standard errors are clustered at the village level and presented in parentheses.
* Statistical signiﬁcance at the 10% level.
** Statistical signiﬁcance at the 5% level.
*** Statistical signiﬁcance at the 1% level.
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This work builds on existing studies of behavioral interven-
tions for increasing children’s micronutrient intake (for a par-
tial review, see Gibson & Anderson, 2009). For example,
Nana, Brouwer, Zagre´, Kok, and Traore´ (2006) found that
promotion of mango and liver consumption increased VA
intakes and serum retinol levels among children in Burkina
Faso and Low et al. (2007) found that promoting orange sweet
potatoes had similar eﬀects in Mozambique. This work moves
beyond the traditionally examined outcomes of intake, nutri-
tional status, and growth to examine whether diet-based inter-
ventions have the potential to improve child health as
measured by morbidity.
The intervention we evaluated was the promotion of biofor-
tiﬁed orange sweet potatoes and we measured its impact on
child diarrhea outcomes. We found that the HarvestPlus
REU intervention reduced diarrhea prevalence and duration
for children in treated villages. We did not ﬁnd that the inter-
vention aﬀected other forms of child illness. However, the
changes in diarrhea suggest that agriculture-based programs
aimed at increasing micronutrient intake via diet change can
signiﬁcantly impact child health.
In earlier analyses of this intervention, de Brauw et al.
(2013) employ causal mediation analysis to determine the pri-
mary pathways by which the REU achieved increases in adop-
tion and estimated increases in vitamin A consumption. They
found that vine distribution had the largest impact on OSP
adoption and vitamin A intakes, and that the behavioral com-
ponent of the intervention had very minimal eﬀects on vitaminA intakes. These ﬁndings provide encouraging evidence that a
program promoting micronutrient-dense alternatives to tradi-
tional varieties can be successful by employing broad messages
of the new variety’s healthful attributes, repeated provision of
starter supplies, and agricultural extension to sustain the crop.
However, consumer acceptance of biofortiﬁed crops may also
be a necessary condition for a program’s success. In this case,
the program was accompanied by consumer acceptance
research, demonstrating that people liked OSP at least as well
as traditional white varieties (Chowdhury, Meenakshi,
Tomlins, & Owori, 2011).
We found that the intervention had greater morbidity
impacts for children with more educated mothers. It may
be that mothers with higher education were better able to
understand the potential health beneﬁts of OSP, and also
to change children’s diets. Children in households where
the head had more education also exhibited stronger impacts,
though not signiﬁcantly so. To the extent that men play a
large role in growing OSP, this result may reﬂect a lower
ability of less educated household heads to adopt and sustain
OSP vines. Such heterogeneities suggest a complementary
eﬀect of education on the success of biofortiﬁcation for
health. The fact that this intervention exhibited some success
in a population with such low levels of education implies it
could be even more eﬀective in populations where a majority
have completed low levels of primary education or better,
holding constant other factors such as preferences for orange
and white sweet potatoes.
We also explored the interaction between exposure to OSP
and recent supplementation of vitamin A. Both the eﬀect of
Table 6. Diarrhea prevalence: Heterogeneous results (full sample)
Testing for heterogeneity by. . .
Child gender Mother educ HH head educ Recent VAS
(1) (2) (3) (4)
Treatment  Post 0.166** 0.301*** 0.281** 0.183**
(0.079) (0.105) (0.126) (0.072)
Treatment  Post  Girl 0.104
(0.093)
Treatment  Post  Low Educ 0.200* 0.216
(0.104) (0.154)
Treatment  Post  VAS
Treatment 0.031 0.272*** 0.201* 0.051
(0.057) (0.099) (0.106) (0.051)
Post 0.022 0.185** 0.126 0.078
(0.071) (0.082) (0.113) (0.061)
Treatment  Girl 0.027
(0.078)
Post  Girl 0.020
(0.079)
Treatment  Low Educ 0.274** 0.238*
(0.106) (0.126)
Post  Low Educ 0.184** 0.139
(0.078) (0.136)
Treatment  VAS
After  VAS
Linear combination .0623 .101** .0647 .0338
(.0514) (.0486) (.0618) (.0901)
Observations 1304 1304 1304 1270
R2 .08 .08 .082 .082
Note: The estimates shown are variations on model (2) from Table 4, employing the same dependent variable. “Girl” indicates that the child is a girl; “low
educ” indicates that the guardian shown in column header did not complete grade 5; “VAS” indicates that the parent reported that the child received
vitamin A supplementation no more than 6 months prior to the data collection regarding diarrhea. Linear combination is the sum of “treatment  post”
and the relevant triple interaction. Estimations also include individual controls for Girl, Low Educ and VAS, as well as stratum ﬁxed eﬀects and the same
controls shown in Table 4. Standard errors are clustered at the village level and presented in parentheses.
* Statistical signiﬁcance at the 10% level.
** Statistical signiﬁcance at the 5% level.
*** Statistical signiﬁcance at the 1% level.
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for children not receiving the alternative (or complementary)
treatment. However, in both cases the diﬀerences were not sta-
tistically signiﬁcant. These strategies may be alternatives
within-child, as each intervention has the ability to reduce
VAD signiﬁcantly. However, from a public health perspective
they are complementary interventions, as neither has the capa-
bility of reaching every child with VAD. Indeed, children in
more densely populated areas are easier to reach with VAS,
while subsistence farming households which are more remote
on average are the targets of biofortiﬁcation, making them
complementary strategies in public health policy.
A ﬁnal caveat is that the severe prevalence of VAD at the
baseline in Mozambique may have contributed to the signiﬁ-
cant impacts on morbidity in Mozambique. In the main inter-
vention report, no impacts on diarrhea prevalence or severity
were found in Uganda, where vitamin A deﬁciency was much
lower and vitamin A capsule distribution was reasonably
widespread (de Brauw et al., 2010). In the Ugandan context,
Meenakshi et al. (2010) estimated that biofortiﬁcation and dis-
semination of sweet potatoes cost $9 to $30 per
disability-life-year (DALY) gained. The cost per DALY
would likely be lower in high VAD contexts such as Mozam-bique, due to the higher potential for impact. In comparison to
biofortiﬁcation, the estimated cost eﬀectiveness of VAS is $73
per DALY gained (estimated in Zambia; Fiedler et al., 2012).
Given the lower cost and potential for spillovers of
agriculture-based diet change across both geographical space
and generations, diet change through biofortiﬁed crops seems
to be a viable complement to current supplementation strate-
gies and a sustainable solution in the longer term for increas-
ing micronutrient intake and improving child health.DISCLOSURE
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of this article.NOTES1. This meta-analysis did not include the DEVTA trial in India, the
largest randomized controlled trial ever conducted regarding VAS
(Awasthi et al., 2013). DEVTA did not ﬁnd impacts on mortality,
however, serious concerns have been raised regarding both the
implementation of VAS in the DEVTA study and its analysis (Habicht
& Victora, 2013; Sloan & Mitra, 2013; Sommer, West, & Martorell, 2013).
Regardless, Mayo-Wilson et al. (2011) note that an update of their
meta-analysis to include the DEVTA trial still estimates a signiﬁcant
reduction in all-cause mortality of 11%.
2. This literature is summarized by both Akachi and Canning (2010) and
Aksan and Chakraborty (2013).
3. Vines were distributed annually to the treatment groups. In the ﬁrst
year, households received two kilograms of OSP for free, with the ability
to purchase up to eight additional kilograms. In the second year,
households only received vines if they could not maintain them; in the
third year, households received up to six kilograms for free, with three
kilograms going to the household head and three kilograms to the spouse.
4. Further detail regarding site selection and program implementation
are provided by Hotz, Loechl, de Brauw et al. (2012).
5. There were in fact two treatment arms, each representing 1/3 of
villages. One treatment was intended to be more intensive in terms of
supervision and support of village-level promoters in the second year of
the intervention. In practice, almost no diﬀerence was observed between
the two treatment groups in terms of outcomes, including the outcomes
used in this paper, and as such they are considered here as a single
treatment group.
6. There are also an additional 85 children under the age three observed
in 2006 who are lost to follow up in 2009, and children aged zero to ﬁve in
133 new households added in 2009.
7. Among reference children who were 12–35 months old at the baseline
and were measured at follow up, the impact on the prevalence of
inadequate intakes was a more modest 17 percentage points.
8. We ﬁnd no signiﬁcant impact of the intervention on respiratory
illness or fever. Signiﬁcant impacts were found for “other” illness,however the imbalance in this indicator at baseline calls the ﬁnding
into question. The results presented here are restricted to diarrhea
prevalence and duration.
9. While most households, and indeed some children, appear in both
rounds of data, our estimates do not include household- or child-ﬁxed
eﬀects. The outcome of interest represents household- or child-level health
status only at an arbitrary, limited point in time, and therefore it is a very
noisy indicator of diarrheal frequency for an individual household or
child. A within-household or within-child estimate would be a poor
representation of the change over time in household or child health status.
An appropriate indicator for that type of analysis would be all diarrheal
occurrences in the past year for the individual, which is not available and
in fact would be exceptionally diﬃcult and expensive to accurately collect.
In contrast, the two-week measure is a clear indicator of village- or
strata-level diarrhea prevalence, allowing estimates of changes in preva-
lence over time.
10. Marginal eﬀects at the mean estimated with a Probit model produce a
similar eﬀect of 12.0 percentage points, signiﬁcant at the 1% level.
11. Estimating Poisson models for this outcome, the marginal eﬀects at
the mean are comparable to coeﬃcients from the OLS model.
12. Approximately 1/3 of households had data for more than one child in
2009. Relying on these we compared OSP consumption by gender across
children within the same household, using household ﬁxed eﬀects. Again
we found slightly higher consumption for boys (two percentage points on
a mean of 60%) but failed to reject that consumption was the same across
genders
13. In only 7% of cases was the mother the head of household.
14. These indicators are not collinear; 37% of children resided in
households where either the head had completed some schooling and
his/her mother had not (34%) or vice versa (3%).
15. Linear combination for VAS without OSP is “VAS + After*VAS
+ Treatment*VAS;” for VAS with OSP it combines these terms with the
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Duration sample
onths All Under 36 months
(3) (4)
* .461*** .428***
) (.081) (.136)
.004 .002
) (.029) (.031)
* .239*** .242*
) (.088) (.125)
0 .015 .011
) (.029) (.027)
* .002 .001
) (.001) (.003)
0 .044 .015
) (.032) (.032)
2 .000 .001
) (.004) (.004)
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Table 7 (continued)
Prevalence sample Duration sample
All Under 36 months All Under 36 months
(1) (2) (3) (4)
Head education .004 .002 .008 .006
(.005) (.005) (.007) (.008)
Mother education .005 .007 .003 .006
(.008) (.008) (.011) (.013)
Constant .042 .049 .129** .132*
(.035) (.034) (.049) (.069)
Observations 1264 768 363 278
R2 .430 .450 .494 .430
Mean DV .376 .233 .295 .198
Note: The dependent variable is a binary indicator for whether the guardian reported that the child ate OSP in the week prior to the interview. Estimations
include stratum ﬁxed eﬀects. Standard errors are clustered at the village level and presented in parentheses.
* Statistical signiﬁcance at the 10% level.
** Statistical signiﬁcance at the 5% level.
*** Statistical signiﬁcance at the 1% level.
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